Chapel Hill, NC, United States of America

M Ross Johnson


Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 122(Granted Patents)


Company Filing History:


Years Active: 1992-2005

Loading Chart...
6 patents (USPTO):

Title: The Contributions of M Ross Johnson in HIV-1 Treatment Innovations

Introduction

M Ross Johnson, an accomplished inventor based in Chapel Hill, NC, has made significant strides in the field of antiviral treatments, particularly for HIV-1 infections. With a total of six patents to his name, Johnson’s innovative approaches have the potential to change the landscape of antiviral therapies.

Latest Patents

Johnson’s recent patents focus on novel methods and compositions for treating HIV-1 infection using antiviral compounds. His inventions explore the use of viral fusion inhibitors, specifically DP-178 and DP-107, in combination with other antiviral therapeutic agents. These combinations are not only more effective than single therapies but in certain scenarios, they exhibit synergistic effects. The innovative mechanisms of DP-178 and DP-107 block HIV transmission while ensuring a non-toxic therapeutic profile, making them ideal candidates for combinatorial antiviral therapy.

Career Highlights

Throughout his career, M Ross Johnson has been associated with prominent companies in the pharmaceutical industry, including Glaxo Inc. and Trimeris, Inc. His commitment to advancing antiviral treatment options showcases his dedication to public health and innovation. His work has had a lasting impact on the realm of viral infection treatments, particularly as he continues to explore and develop novel therapeutic strategies.

Collaborations

Johnson has collaborated with notable peers in his field, including Jeffrey M Besterman and Michael G Evans. These collaborations have fostered an environment of creativity and innovation, advancing the research and development of antiviral combinations that are crucial for effective HIV treatment.

Conclusion

M Ross Johnson’s contributions to the field of antiviral therapies, particularly for HIV-1, illustrate the importance of innovation in medicine. By blending scientific insight with patented inventions, Johnson continues to pave the way for enhanced treatment options that can significantly impact patient care in the fight against viral infections. His work exemplifies the crucial role of inventors in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…